现代医药卫生
現代醫藥衛生
현대의약위생
MODERN MEDICINE HEALTH
2014年
17期
2563-2565
,共3页
罗娟%秦爱平%李浪波%陈凯
囉娟%秦愛平%李浪波%陳凱
라연%진애평%리랑파%진개
糖尿病,2型%糖尿病血管病变%血糖%氧化性应激%格列齐特%老年人%瑞格列奈
糖尿病,2型%糖尿病血管病變%血糖%氧化性應激%格列齊特%老年人%瑞格列奈
당뇨병,2형%당뇨병혈관병변%혈당%양화성응격%격렬제특%노년인%서격렬내
Diabetes mellitus,type 2%Diabetic angiopathies%Blood glucose%Oxidative stress%Gliclazide%Aged%Repaglinide
目的:观察初诊老年2型糖尿病患者血糖波动对氧化应激的影响,比较分析瑞格列奈与格列齐特对患者血糖波动及氧化应激的影响。方法将2013年1~12月60例初诊老年2型糖尿病患者分为瑞格列奈组和格列齐特组各30例。分别予以瑞格列奈和格列齐特治疗8周,采用动态血糖监测系统的日内平均血糖波动幅度(MAGE)以及日间血糖平均绝对差(MODD)评估血糖波动,同时测定谷胱甘肽过氧化物酶(GSH-Px)、超氧化物歧化酶(SOD)、丙二醛(MDA)以反映患者氧化应激水平。结果老年2型糖尿病患者血清GSH-Px、SOD水平与MAGE、MODD呈负相关(P<0.05),MDA水平与MAGE、MODD呈正相关(P<0.01)。瑞格列奈组和格列齐特组治疗后MAGE、MODD、MDA水平降低,血清GSH-Px、SOD水平增加,各指标与治疗前比较,差异均有统计学意义(P<0.01);但两组治疗后比较,差异无统计学意义(P>0.05)。结论初诊老年2型糖尿病患者血糖波动与氧化应激水平存在显著相关性。瑞格列奈与格列齐特均可降低初诊老年2型糖尿病患者的血糖波动及氧化应激水平,2种药物疗效相似。
目的:觀察初診老年2型糖尿病患者血糖波動對氧化應激的影響,比較分析瑞格列奈與格列齊特對患者血糖波動及氧化應激的影響。方法將2013年1~12月60例初診老年2型糖尿病患者分為瑞格列奈組和格列齊特組各30例。分彆予以瑞格列奈和格列齊特治療8週,採用動態血糖鑑測繫統的日內平均血糖波動幅度(MAGE)以及日間血糖平均絕對差(MODD)評估血糖波動,同時測定穀胱甘肽過氧化物酶(GSH-Px)、超氧化物歧化酶(SOD)、丙二醛(MDA)以反映患者氧化應激水平。結果老年2型糖尿病患者血清GSH-Px、SOD水平與MAGE、MODD呈負相關(P<0.05),MDA水平與MAGE、MODD呈正相關(P<0.01)。瑞格列奈組和格列齊特組治療後MAGE、MODD、MDA水平降低,血清GSH-Px、SOD水平增加,各指標與治療前比較,差異均有統計學意義(P<0.01);但兩組治療後比較,差異無統計學意義(P>0.05)。結論初診老年2型糖尿病患者血糖波動與氧化應激水平存在顯著相關性。瑞格列奈與格列齊特均可降低初診老年2型糖尿病患者的血糖波動及氧化應激水平,2種藥物療效相似。
목적:관찰초진노년2형당뇨병환자혈당파동대양화응격적영향,비교분석서격렬내여격렬제특대환자혈당파동급양화응격적영향。방법장2013년1~12월60례초진노년2형당뇨병환자분위서격렬내조화격렬제특조각30례。분별여이서격렬내화격렬제특치료8주,채용동태혈당감측계통적일내평균혈당파동폭도(MAGE)이급일간혈당평균절대차(MODD)평고혈당파동,동시측정곡광감태과양화물매(GSH-Px)、초양화물기화매(SOD)、병이철(MDA)이반영환자양화응격수평。결과노년2형당뇨병환자혈청GSH-Px、SOD수평여MAGE、MODD정부상관(P<0.05),MDA수평여MAGE、MODD정정상관(P<0.01)。서격렬내조화격렬제특조치료후MAGE、MODD、MDA수평강저,혈청GSH-Px、SOD수평증가,각지표여치료전비교,차이균유통계학의의(P<0.01);단량조치료후비교,차이무통계학의의(P>0.05)。결론초진노년2형당뇨병환자혈당파동여양화응격수평존재현저상관성。서격렬내여격렬제특균가강저초진노년2형당뇨병환자적혈당파동급양화응격수평,2충약물료효상사。
Objective To investigate the effect of glucose variability on oxidative stress in newly-diagnosed elderly pa-tients with type 2 diabetes mellitus(T2DM),and compare the influence of repaglinide and gliclazide on glucose variability and ox-idative stress. Methods A total of 60 elderly patients with newly-diagnosed T2DM from January to December of 2013 were divid-ed into repaglinide group and gliclazide group,30 cases in each group,which received repaglinide and gliclazide respectively for 8-week treatment. The glucose variability was evaluated by mean amplitude of glycemic excursions (MAGE) and mean of daily differences(MODD) of continuous glucose monitoring system(CGMS),meanwhile to detect the Glutathione Peroxidase(GSH-Px), Superoxide Dismutase(SOD) and Maleic Dialdehyde(MDA) to reflect the level of oxidative stress. Results The levels of GSH-Px and SOD in elderly patients with T2DM were negatively related with MAGE and MODD(P<0.05),while the MDA level was positively related with MAGE and MODD(P<0.01). The levels of MAGE,MODD and MDA in both groups decreased after treat-ment,and the levels of serum GSH-Px and SOD increased,the difference of above indicators in both groups before and after treat-ment had statistical significance(P<0.01),but the comparison between the two groups on the above indicators showed no statisti-cally significant difference(P>0.05). Conclusion The serum oxidative stress levels are significantly correlated with glucose variability in newly-diagnosed elderly patients with T2DM. Both repaglinide and gliclazide can reduce the amplitude of glucose variability and oxidative stress levels in newly-diagnosed elderly patients with T2DM with similar effect.